850349-22-3 Usage
Uses
Used in Medicinal Chemistry:
2-AZETIDIN-1-YL-5-BROMO-PYRIMIDINE is used as a building block for the synthesis of complex organic molecules in the field of medicinal chemistry. Its unique structure and functional groups contribute to the development of new chemical entities with potential pharmaceutical relevance.
Used in Pharmaceutical Drug Development:
2-AZETIDIN-1-YL-5-BROMO-PYRIMIDINE is used as a key component in the creation of new pharmaceutical drugs. Its potential biological activities and the presence of both pyrimidine and azetidine rings make it a valuable candidate for further research and exploration in drug development.
Used in Chemical Modifications:
The bromine atom in 2-AZETIDIN-1-YL-5-BROMO-PYRIMIDINE provides a site for further chemical modifications, making it a versatile tool for the synthesis of new chemical entities with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 850349-22-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,3,4 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 850349-22:
(8*8)+(7*5)+(6*0)+(5*3)+(4*4)+(3*9)+(2*2)+(1*2)=163
163 % 10 = 3
So 850349-22-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H8BrN3/c8-6-4-9-7(10-5-6)11-2-1-3-11/h4-5H,1-3H2
850349-22-3Relevant academic research and scientific papers
SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
-
Paragraph 0380; 0381; 0382, (2016/09/26)
Provided is a sulfonamide derivative represented by the following general formula (1) and having an α4 integrin inhibitory effect with high selectivity with a low effect on α4β1 and a high effect on α4β7, or a pharmaceutically acceptable salt thereof (in the general formula (1), A, B, D, E, R41, and a to h are as described in the description).
SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF
-
Paragraph 1313-11314, (2015/02/25)
Provided are sulfonamide derivatives of a specific chemical structure in which a sulfonamide group having, as a substituent, a phenyl group or a heterocyclic group having a hetero atom(s) as a constituent element(s) is present at its terminal, and pharmaceutically acceptable salts thereof. These compounds are novel compounds having excellent α4 integrin-inhibitory action.
